Citation: | TANG Lingling, FENG Li, YANG Qi, XIONG Lu, LUO Feng, LI Run. Experimental study on effect of Xingqi Huoxue Zhitong Paste on transfusion-induced phlebitis and its impact on related inflammatory factors[J]. Journal of Clinical Medicine in Practice, 2024, 28(13): 126-130. DOI: 10.7619/jcmp.20233829 |
To investigate the application effect of external treatment method of Xingqi Huoxue Zhitong Paste in the treatment of phlebitis.
Using mannitol as an inflammatory agent, a phlebitis model was established by infusion into the ear marginal vein of rabbits. Successfully modeled rabbits were randomly divided into four subgroups for intervention, while the blank control group was routinely raised without any intervention. After the intervention, the improvement effect of Xingqi Huoxue Zhitong Paste on mannitol-induced transfusion-induced phlebitis in rabbits was explored by observing the manifestations of phlebitis, serum interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and vascular endothelial growth factor A (VEGF-A) levels.
The success rate was up to 90.0%. On the first day of treatment, there were 8 ineffective cases and 1 effective case in the saline group; 6 ineffective cases and 3 effective cases in the hirudoid group; 7 ineffective cases and 2 effective cases in the magnesium sulfate group; 7 ineffective cases and 2 effective cases in the Xingqi Huoxue Zhitong Paste group. There was no significant difference in the curative effect among the four groups (P=0.431). On the fourth day of treatment, there were 5 ineffective cases, 2 effective cases, and 2 markedly effective cases in the saline group; 1 effective case, 5 markedly effective cases, and 3 cured cases in the hirudoid group; 2 effective cases, 5 markedly effective cases, and 2 cured cases in the magnesium sulfate group; 2 effective cases, 4 markedly effective cases, and 3 cured cases in the Xingqi Huoxue Zhitong Paste group. On the fourth day of treatment, compared with the saline group, the curative effects of the hirudoid group (P=0.001), the magnesium sulfate group (P=0.020), and the Xingqi Huoxue Zhitong Paste group (P=0.003) were statistically significant. There was no significant difference in curative effect in the magnesium sulfate group and the Xingqi Huoxue Zhitong Paste group when compared with the hirudoid group (P>0.05); there was no significant difference in curative effect in the Hirudoid group and the Xingqi Huoxue Zhitong Paste group when compared with the magnesium sulfate group (P>0.05); there was no significant difference in curative effect in the hirudoid group and the magnesium sulfate group when compared with the Xingqi Huoxue Zhitong Paste group (P>0.05). The effective rate of the saline group was 11.1%, and the cure rate was 0%. The effective rate of the hirudoid group was 100.0%, and the cure rate was 33.3%. The effective rate of the magnesium sulfate group was 77.7%, and the cure rate was 44.4%. The effective rate of the Xingqi Huoxue Zhitong Paste group was 66.7%, and the cure rate was 22.2%. The drug effectiveness of the Xingqi Huoxue Zhitong Paste group, the hirudoid group, and the magnesium sulfate group was higher than that of the saline group (P < 0.05). After the intervention, the levels of serum inflammatory factors IL-6, TNF-α, and VEGF-A in the four model subgroups were statistically significant compared with the blank control group (P < 0.05). The levels of serum inflammatory factors IL-6, TNF-α, and VEGF-A in the saline group showed significant difference from those in the hirudoid group, the magnesium sulfate group, and the Xingqi Huoxue Zhitong Paste group (P < 0.05). Compared with the hirudoid group, the differences in serum inflammatory factors IL-6, TNF-α, and VEGF-A contents in the magnesium sulfate group and the Xingqi Huoxue Zhitong Paste group were statistically significant (P < 0.05). The inflammatory factor levels in the blank control group were the lowest, while those in the normal saline group were the highest.
Xingqi Huoxue Zhitong Paste group has an improving effect on mannitol-induced infusion phlebitis in rabbits, but its efficacy is inferior to that of the commonly used hirudoid ointment. Therefore, appropriate adjustments and improvements can be made to the drug formula to enhance its effectiveness.
[1] |
MARSH N, WEBSTER J, ULLMAN A J, et al. Peripheral intravenous catheter non-infectious complications in adults: a systematic review and meta-analysis[J]. J Adv Nurs, 2020, 76(12): 3346-3362. doi: 10.1111/jan.14565
|
[2] |
白萍, 魏永婷, 孙智超, 等. 肿瘤手术病人外周静脉输液性静脉炎发生风险预测模型的构建[J]. 护理研究, 2023, 37(11): 1914-1920. https://www.cnki.com.cn/Article/CJFDTOTAL-SXHZ202311003.htm
|
[3] |
陈亚美. 外周静脉导管相关静脉炎风险评估模型的构建[D]. 苏州: 苏州大学, 2019.
|
[4] |
林永乐. 复方黄连搽剂用于输液性静脉炎的实验研究[D]. 南宁: 广西医科大学, 2018.
|
[5] |
付常庚, 樊炜静, 陈泽吉, 等. 中医外治法在血栓性浅静脉炎防治中的应用[J]. 现代中西医结合杂志, 2019, 28(35): 3977-3981. doi: 10.3969/j.issn.1008-8849.2019.35.027
|
[6] |
罗春绸, 蔡惠贞, 姚秀娥, 等. 地塞米松溶液封管预防经外周静脉导管输注甘露醇所致静脉炎的应用研究[J]. 解放军护理杂志, 2021, 38(2): 22-25. doi: 10.3969/j.issn.1008-9993.2021.02.006
|
[7] |
庄惠人. 酚妥拉明加绿药膏在处理胺碘酮致渗漏性静脉炎的效果研究[D]. 上海: 同济大学, 2018.
|
[8] |
宋凌霞, 张咏梅, 王玲, 等. 虎杖膏外敷预防甘露醇所致静脉炎的实验研究[J]. 重庆医学, 2015, 44(12): 1686-1688. doi: 10.3969/j.issn.1671-8348.2015.12.035
|
[9] |
张咏梅, 宋凌霞, 王玲, 等. 虎杖膏预防高渗药液致兔耳缘静脉炎的实验研究[J]. 护理学杂志, 2013, 28(21): 36-38. doi: 10.3870/hlxzz.2013.21.036
|
[10] |
冯莺, 俞琦, 周玲, 等. 三黄软膏防治诺维本所致静脉炎的实验研究[J]. 中华护理杂志, 2012, 47(4): 341-343. doi: 10.3761/j.issn.0254-1769.2012.04.020
|
[11] |
鲍冠君, 冯莺, 俞琦, 等. 三黄软膏不同时段外敷防治诺维本致静脉炎的实验研究[J]. 护理学杂志, 2013, 28(7): 19-20. doi: 10.3870/hlxzz.2013.07.019
|
[12] |
赵洁琼, 魏巍, 陶凤, 等. 薄型泡沫敷料在防治20%甘露醇所致静脉炎中的应用效果[J]. 海军医学杂志, 2022, 43(9): 1015-1016. https://www.cnki.com.cn/Article/CJFDTOTAL-HJYX202209037.htm
|
[13] |
李红梅, 刘爱兰, 韩艳, 等. 医用冷敷贴预防妇科肿瘤患者化疗性静脉炎的效果[J]. 实用临床医药杂志, 2020, 24(22): 10-13. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202022003.htm
|
[14] |
刘宏飞, 唐红福, 唐艳娇, 等. 喜疗妥治疗吡柔比星所致40例化疗性静脉炎的临床观察[J]. 齐齐哈尔医学院学报, 2018, 39(1): 51-52. doi: 10.3969/j.issn.1002-1256.2018.01.021
|
[15] |
谭静, 林红强, 王亚茹, 等. 三棱的化学成分、药理作用及临床应用研究进展[J]. 特产研究, 2018, 40(4): 109-113. https://www.cnki.com.cn/Article/CJFDTOTAL-TCYA201804024.htm
|
[16] |
黄盼, 王倩, 周改莲, 等. 广西莪术不同部位挥发性成分的GC-MS差异性分析[J]. 时珍国医国药, 2020, 31(10): 2366-2368. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY202010018.htm
|
[17] |
叶琪, 苏宏娜, 杨艺, 等. 乳香有效成分治疗冠心病的作用机制研究进展[J]. 中草药, 2023, 54(16): 5379-5389. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO202316023.htm
|
[18] |
杨宝, 徐莲莲, 陈芳有, 等. 没药化学成分及抗炎活性研究[J]. 中草药, 2023, 54(9): 2716-2721. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO202309003.htm
|
[19] |
刘晓龙, 李春燕, 肖先, 等. 黄连主要活性成分及药理作用研究进展[J]. 新乡医学院学报, 2023, 40(8): 784-790. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYX202308018.htm
|
[20] |
周迎光, 陈建斌, 陈双, 等. 桃红四物汤联合五苓散加减在老年股骨粗隆间骨折患者围术期的应用[J]. 实用临床医药杂志, 2021, 25(20): 85-88,92. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202120018.htm
|
[21] |
罗琼, 李天一, 张珂, 等. 紫草防治血热证的活性成分挖掘与机制探讨[J]. 中国药理学通报, 2023, 39(8): 1470-1477. https://www.cnki.com.cn/Article/CJFDTOTAL-YAOL202308012.htm
|
[22] |
张丽, 王绪平, 黄孝闻, 等. 血竭及龙血竭化学成分、药理作用研究进展[J]. 中国现代应用药学, 2019, 36(20): 2605-2611. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYD201920025.htm
|